MMP-2: is too low as bad as too high in the cardiovascular system?
Eugenio Hardy(Center of Molecular Immunology (Cuba)), Carlos Fernández-Patrón(University of Alberta), Anette Hardy-Sosa(University of Electronic Science and Technology of China)
American Journal of Physiology-Heart and Circulatory Physiology
August 17, 2018
Cited by 69
Related Papers
Vascular Matrix Metalloproteinase-2 Cleaves Big Endothelin-1 Yielding a Novel Vasoconstrictor
|Circulation Research|1999|364
Differential Regulation of Platelet Aggregation by Matrix Metalloproteinases-9 and -2
|Thrombosis and Haemostasis|1999|190
Agonist-Induced Activation of Matrix Metalloproteinase-7 Promotes Vasoconstriction Through the Epidermal Growth Factor–Receptor Pathway
|Circulation Research|2003|181
Vascular Matrix Metalloproteinase-2–Dependent Cleavage of Calcitonin Gene-Related Peptide Promotes Vasoconstriction
|Circulation Research|2000|176